ImmuCell Announces Product Sales Growth and Other Financial Results for Third Quarter of 2011
(firmenpresse) - PORTLAND, ME -- (Marketwire) -- 11/14/11 -- (NASDAQ: ICCC) today announced the results of its operations for the three-month and nine-month periods ended September 30, 2011.
During the three-month period ended September 30, 2011, product sales increased by 15%, or $130,000, to $1,003,000 in comparison to the same period in 2010. During the nine-month period ended September 30, 2011, product sales increased by 17%, or $543,000, to $3,807,000 in comparison to the same period in 2010. During the nine-month period ended September 30, 2011, sales of our animal health products (excluding sales of our water diagnostic reagents) increased by 22%.
"A 26% increase in sales of our lead product, ®, during the first nine months of 2011 over the same period in 2010, demonstrates a solid return on our increased investment in sales and marketing," commented Michael F. Brigham, President and CEO. "During the third quarter of 2011, sales of ® increased by 22% over the same period in 2010, representing the fourth consecutive quarter of double digit growth in sales of this product."
Mr. Brigham further commented, "This growth in our commercial business is important to us while we seek a partner to complete the development of ®."
The loss before income taxes was $211,000 during the three-month period ended September 30, 2011, in comparison to a loss before income taxes of $351,000 during the same period in 2010. The net loss was $128,000, or $0.04 per share, during the three-month period ended September 30, 2011, in comparison to a net loss of $197,000, or $0.07 per share, during the same period in 2010.
The loss before income taxes was $699,000 during the nine-month period ended September 30, 2011, in comparison to a loss before income taxes of $452,000 during the same period in 2010. The net loss was $409,000, or $0.14 per share, during the nine-month period ended September 30, 2011, in comparison to a net loss of $257,000, or $0.09 per share, during the same period in 2010.
Cash, cash equivalents and short-term investments increased by 3%, or $119,000, to $4,745,000 at September 30, 2011 as compared to $4,626,000 at December 31, 2010. Stockholders' equity decreased by 3%, or $288,000, to $8,994,000 at September 30, 2011 as compared to $9,282,000 at December 31, 2010. The Company had 2,999,000 shares of common stock outstanding as of September 30, 2011.
About ImmuCell:
ImmuCell Corporation's (NASDAQ: ICCC) purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries. Press releases and other information about the Company are available at our web-site, ().
Michael F. Brigham
President and Chief Executive Officer
(207) 878-2770 Ext. 3106
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.11.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1056630
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PORTLAND, ME
Phone:
Kategorie:
Livestock
Anmerkungen:
Diese Pressemitteilung wurde bisher 200 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ImmuCell Announces Product Sales Growth and Other Financial Results for Third Quarter of 2011
"
steht unter der journalistisch-redaktionellen Verantwortung von
ImmuCell Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
